The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Translational and Clinical Endocrinology
Volume 15 - 2024 |
doi: 10.3389/fendo.2024.1416121
Bone health in transgender assigned female at birth people: effects of gender affirming hormone therapy and gonadectomy
Provisionally accepted- 1 IRCCS University Hospital of Bologna Sant Orsola Polyclinic, Bologna, Italy
- 2 Department of Medical and Surgical Sciences, University of Bologna, Bologna, Emilia-Romagna, Italy
- 3 Research and Innovation Unit, Sant'Orsola-Malpighi Polyclinic, Bologna, Emilia-Romagna, Italy
Introduction -Gender affirming hormone therapy (GAHT) and gender affirming surgery (GAS) may be desired by transgender and gender diverse (TGD) individuals who want to affirm their gender identity. Testosterone is the basis of GAHT for transgender individuals assigned female at birth (AFAB), while GAS can involve hysterectomy, bilateral salpingectomy, bilateral oophorectomy (BO), thorax masculinization and phalloplasty. Our study aimed to evaluate the effects of GAHT on the bone health of TGD AFAB individuals who have undergone or not undergone BO.Methods -This was a single-center, longitudinal study with retrospectively collected data. TGD AFAB GAHT-naïve individuals were enrolled and underwent dual Xray absorptiometry scans and laboratory tests (hormonal, bone metabolism parameters) at baseline and after 5 and 10 years of GAHT.Results -Two hundred and forty-three TGD AFAB people were included in this study. Seventy-five subjects had completed data for 5 years and 19 subjects for 10 years of GAHT. At baseline, low bone density (Z-score < -2.0) was found in 2.5% (6/243) of subjects for lumbar spine (LS) while total hip (TH), femoral neck (FN) Z-scores and laboratory tests were within the normal female range. After stratifying by physical activity, the physically active group showed significantly higher LS BMD and Z-scores (p≤0.05). Five years after the start of GAHT, a significant reduction in LS (p≤0.05), TH (p≤0.001) and FN (p≤0.01) Z-scores was detected. A significant reduction in the Z-scores of all three bone sites was observed only in the subgroup that had undergone BO. After 5 years of GAHT, estradiol levels were significantly decreased compared to baseline (p≤0.001). Significantly higher estradiol levels were detected in the 5-year no-BO subgroup compared to the 5-year BO subgroup (p≤0.001). A significant reduction in LS and TH Z-scores were observed after 10 years of GAHT. At this time, estradiol levels were significantly decreased compared to baseline (p≤0.01).Bone density in TGD AFAB individuals is comparable to their peers prior to GAHT and BO but those subjects who underwent BO had a reduced Z-score at LS, FN, and TH after 5 years and at LS after 10 years of GAHT.
Keywords: Bone health, transgender, AFAB, Testosterone, DXA, GAHT, bilateral oophorectomy (BO), Bone Mineral Density (BMD)
Received: 11 Apr 2024; Accepted: 03 Sep 2024.
Copyright: © 2024 Sanna, Lami, Giacomelli, Alvisi, Paccapelo, Seracchioli and Meriggiola. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Maria Cristina Meriggiola, IRCCS University Hospital of Bologna Sant Orsola Polyclinic, Bologna, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.